Showing results (121-130 of 829) with videos related to

Sort By:
Pageof 83
Journal of Diabetes and Its Complications|October 23, 2016
Pleiotropic effects of liraglutide treatment on renal risk factors in type 2 diabetes: Individual effects of treatmentEmilie Hein Zobel, Bernt Johan von Scholten, Morten Lindhardt, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|August 10, 2011
Impact of aliskiren treatment on urinary aldosterone levels in patients with type 2 diabetes and nephropathy: an AVOID substudyFrederik Persson, Julia B Lewis, Edmund J Lewis, et al.
Diabetes, Obesity & Metabolism|January 22, 2019
Pleiotropic effects of liraglutide in patients with type 2 diabetes and moderate renal impairment: Individual effects of treatmentEmilie H Zobel, Bernt J von Scholten, Bryan Goldman, et al.
Diabetes, Obesity & Metabolism|March 5, 2023
Sotagliflozin, a dual sodium-glucose co-transporter-1 and sodium-glucose co-transporter-2 inhibitor, reduces the risk of cardiovascular and kidney disease, as assessed by the Steno T1 Risk Engine in adults with type 1 diabetesElisabeth B Stougaard, Peter Rossing, Dorte Vistisen, et al.
Diabetes Care|July 29, 2003
Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trialKasper Rossing, Peter Jacobsen, Lotte Pietraszek, et al.
Journal of the American Society of Nephrology : JASN|July 11, 2006
Microalbuminuria as an early marker for cardiovascular diseaseDick de Zeeuw, Hans-Henrik Parving, Robert H Henning
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 15, 2007
Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patientsMaria Lajer, Lise Tarnow, Anders Jorsal, et al.
Diabetes|June 5, 2010
Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up studyJohanna W M Nin, Anders Jorsal, Isabel Ferreira, et al.
Diabetes|June 8, 2017
Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease in Individuals With Type 1 Diabetes: A 12-Year Follow-up StudyNordin M J Hanssen, Jean L J M Scheijen, Anders Jorsal, et al.
BMJ Open|September 21, 2024
Cohort profile: the PRIMETIME 1 (PRecIsion MEdicine based on kidney TIssue Molecular interrogation in diabetic nEphropathy) cohort - a longitudinal Danish nationwide study of individuals with diabetes and a performed kidney biopsyKarina Haar Jensen, Vanja Kosjerina, Ditte Hansen, et al.
Pageof 83